Nanomaterial-enabled drug transport systems: a comprehensive exploration of current developments and future avenues in therapeutic delivery
Authors:
- 4 November 2024
- journal article
- review article
- Published by Springer Nature in 3 Biotech
- Vol. 14 (12) , 289
Abstract
Over the years, nanotechnology has gained popularity as a viable solution to address gene and drug delivery challenges over conventional methods. Extensive research has been conducted on nanosystems that consist of organic/inorganic materials, drugs, and its biocompatibility become the primary goal of improving drug delivery. Various surface modification methods help focus targeted and controlled drug release, further enabling multidrug delivery also. This newer technology ensures the stability of drugs that can unravel the mechanisms involved in cellular processes of disease development and its management. Tailored medication delivery provides benefits such as therapy, controlled release, and reduced adverse effects, which are especially important for controlling illnesses like cancer. However, multifunctional nanocarriers that possess high viscoelasticity, extended circulation half-life, biocompatibility, and biodegradability face some challenges and limitations too in human bodies. To produce a consistent therapeutic platform based on complex three-dimensional nanoparticles, careful design and engineering, thorough orthogonal analysis methods, and reproducible scale-up and manufacturing processes will be required in the future. Safety and effectiveness of nano-based drug delivery should be thoroughly investigated in preclinical and clinical trials, especially when considering biodistribution, targeting specific areas, and potential immunological toxicities. Overall, the current review article explores the advancements in nanotechnology, specific to nanomaterial-enabled drug delivery systems, carrier fabrication techniques and modifications, disease management, clinical research, applications, limitations, and future challenges. The work portrays how nanomedicine distribution affects healthcare with an emphasis on the developments in drug delivery techniques.Keywords
This publication has 216 references indexed in Scilit:
- Reactive Oxygen Species‐Scavenging Nanosystems in the Treatment of Diabetic WoundsAdvanced Healthcare Materials, 2023
- Electrospun nanofibers for drug delivery applications: Methods and mechanismPolymers for Advanced Technologies, 2022
- Advances in endocrine toxicity of nanomaterials and mechanism in hormone secretion disordersJournal of Applied Toxicology, 2021
- Reactive Oxygen Species‐Regulating Strategies Based on Nanomaterials for Disease TreatmentAdvanced Science, 2020
- Nucleic Acid–Based Functional Nanomaterials as Advanced Cancer TherapeuticsSmall, 2019
- Dose‐Dependent Therapeutic Distinction between Active and Passive Targeting Revealed Using Transferrin‐Coated PGMA NanoparticlesSmall, 2015
- Microencapsulation of coco fatty acid mixture for thermal energy storage with phase change materialInternational Journal of Energy Research, 2005
- Novel mechanism of hybrid liposomes‐induced apoptosis in human tumor cellsInternational Journal of Cancer, 2005
- Electrospinning of nanofibersJournal of Applied Polymer Science, 2005
- Two‐Time Window and Multiangle Photon Correlation Spectroscopy Size and Zeta Potential Analysis — Highly Sensitive Rapid Assay for Dispersion StabilityJournal of Pharmaceutical Sciences, 2000